GATA1 (Ab-142) Antibody

Basic Research Questions

• What is GATA1 and what is its biological significance?

  GATA1 is a crucial transcription factor involved in hematopoiesis that serves as a general switch factor for erythroid development. It functions as both a transcriptional activator and repressor, binding to DNA sites with the consensus sequence 5'-[AT]GATA[AG]-3' within regulatory regions of globin genes and other genes expressed in erythroid cells . GATA1 plays a vital role in erythroid differentiation by activating the transcription of genes including HBB, HBG1/2, ALAS2, and HMBS . Mutations in the GATA1 gene are linked to several hematological disorders, including anemia, thrombocytopenia, Down syndrome-related transient abnormal myelopoiesis (DS-TAM), and acute megakaryocytic leukemia (DS-AMKL) .

• What epitope does the GATA1 (Ab-142) Antibody recognize?

  The GATA1 (Ab-142) Antibody is a rabbit polyclonal antibody that specifically recognizes a non-phosphopeptide region around amino acids 140-144 (sequence R-L-S-P-D) in human GATA1 . This region is particularly significant as it contains the Serine 142 phosphorylation site, which plays a crucial role in GATA1 function. The antibody detects endogenous levels of total GATA1 protein regardless of its phosphorylation status at this site, making it distinct from phospho-specific antibodies targeting the same region .

• What applications is the GATA1 (Ab-142) Antibody validated for?

  The GATA1 (Ab-142) Antibody has been validated for multiple research applications including:

  Application	Working Dilution	Notes
  Western Blot (WB)	1:500-1:1000	Detects endogenous GATA1 protein
  Immunohistochemistry (IHC)	1:50-1:200	Works on fixed tissue sections
  Immunofluorescence (IF)	1:100-1:200	For cellular localization studies
  ELISA	Variable	For quantitative analysis

  The antibody has shown consistent results across these applications, with particular strength in Western blot analysis for detecting native GATA1 protein in cellular lysates .

• What species reactivity does the GATA1 (Ab-142) Antibody demonstrate?

  The GATA1 (Ab-142) Antibody has been validated to react with GATA1 protein from multiple species, including human, mouse, and rat samples . This cross-species reactivity makes the antibody versatile for comparative studies across different experimental models. The epitope recognized by this antibody is relatively conserved across these species, explaining its broad reactivity profile.

• What are the optimal storage and handling conditions for GATA1 (Ab-142) Antibody?

  For maximum stability and activity retention, the GATA1 (Ab-142) Antibody should be stored at -20°C or -80°C, avoiding repeated freeze-thaw cycles . The antibody is typically supplied at 1.0mg/mL in phosphate buffered saline (without Mg²⁺ and Ca²⁺), pH 7.4, 150mM NaCl, with 0.02% sodium azide and 50% glycerol as stabilizers . When handling, aliquoting the antibody into smaller volumes upon receipt is recommended to minimize freeze-thaw cycles that can degrade antibody performance.

Advanced Research Questions

• How can GATA1 (Ab-142) Antibody be optimized for Western blot analysis of complex samples?

  For optimal Western blot results with GATA1 (Ab-142) Antibody, consider the following methodological approach:

  1. Sample preparation: Use RIPA buffer supplemented with protease and phosphatase inhibitors for efficient extraction of nuclear GATA1 protein

  2. Loading: 20-40μg of total protein per lane typically yields optimal results

  3. Transfer: Semi-dry transfer at 15V for 30 minutes or wet transfer at 30V overnight at 4°C

  4. Blocking: 5% non-fat dry milk in TBST for 1 hour at room temperature

  5. Primary antibody incubation: Dilute antibody 1:500-1:1000 in 5% BSA/TBST and incubate overnight at 4°C

  6. Detection: Use HRP-conjugated secondary antibodies with enhanced chemiluminescence

  Including positive controls (K562 erythroleukemia cell lysates) and negative controls (non-erythroid cell lines with minimal GATA1 expression) is essential for proper interpretation of results .

• What are the key differences between using GATA1 (Ab-142) Antibody versus phospho-specific GATA1 antibodies?

  Understanding the distinctions between these antibody types is crucial for experimental design:

  Characteristic	GATA1 (Ab-142) Antibody	Phospho-Specific GATA1 Antibodies
  Target epitope	Total GATA1 near S142	Specifically phosphorylated residues (S142 or S310)
  Research application	Measuring total GATA1 expression	Assessing activation status of GATA1
  Cellular signaling studies	General GATA1 expression patterns	Signal-dependent GATA1 activation
  Experimental controls	Less stringent phosphatase treatment	Requires phosphatase controls

  For comprehensive studies of GATA1 function, using both total GATA1 antibodies and phospho-specific antibodies provides complementary information about both expression levels and activation status .

• How can I effectively use GATA1 (Ab-142) Antibody to study GATA1 protein complexes?

  GATA1 forms multiple distinct protein complexes that regulate its function in hematopoiesis. To study these complexes using GATA1 (Ab-142) Antibody:

  1. Perform co-immunoprecipitation (Co-IP) experiments using the antibody at 1:50 dilution with 500μg of nuclear extract

  2. Use gentle lysis buffers (150mM NaCl, 20mM Tris pH 7.5, 1% Triton X-100) to preserve protein-protein interactions

  3. Cross-validate interactions using reverse Co-IP with antibodies against known GATA1 partners (FOG-1, TAL-1, Ldb1)

  4. Confirm specificity using GATA1-deficient cells as negative controls

  Research has demonstrated that GATA1 forms at least five distinct complexes: with FOG-1 and MeCP1, with FOG-1 alone, with TAL-1 (and Ldb1), with Gfi-1b, and with ACF/WCRF . Each complex has different functional significance in erythroid development and differentiation.

• What methodological considerations are important when using GATA1 (Ab-142) Antibody to study hematological disorders?

  When investigating hematological disorders with this antibody:

  1. Use appropriate disease models - patient-derived samples, CRISPR-edited cell lines, or knockdown models of relevant ribosomal proteins for Diamond-Blackfan anemia (DBA)

  2. Compare GATA1 expression in disease vs. healthy controls using quantitative Western blot analysis

  3. Assess subcellular localization using immunofluorescence to detect potential mislocalization

  4. Combine with functional assays (e.g., erythroid differentiation assays) to correlate GATA1 expression with phenotype

  5. Consider the impact of GATA1 mutations on protein expression - some mutations lead to expression of a short GATA1 isoform lacking the N-terminal transactivation domain (N-TAD)

  Studies have demonstrated that regulated GATA1 expression is sufficient to overcome erythroid maturation arrest in models of DBA and in primary DBA patient samples, highlighting the therapeutic potential of modulating GATA1 activity .

• How can I validate the specificity of GATA1 (Ab-142) Antibody in my experimental system?

  Rigorous antibody validation is essential for reliable results. Implement the following validation strategy:

  1. Perform peptide competition assays using the immunizing peptide

  2. Include GATA1 knockout/knockdown controls (e.g., CRISPR-edited cell lines or shRNA-treated cells)

  3. Test multiple cell lines with known GATA1 expression profiles (K562 as positive, non-hematopoietic cells as negative)

  4. Compare results with a different GATA1 antibody recognizing a distinct epitope

  5. Verify molecular weight (approximately 47 kDa for full-length GATA1, ~40 kDa for the short isoform)

  Complete validation should include at least three independent methods to confirm antibody specificity and rule out non-specific binding .

• What cellular models are most appropriate for studying GATA1 function with this antibody?

  Select research models based on your specific research questions:

  Cellular Model	Advantages	Applications
  K562 cells	Erythroleukemia cell line with high GATA1 expression	Basic GATA1 function studies
  G1E cells	GATA1-null erythroblast line	Rescue experiments with exogenous GATA1
  MEL cells	Murine erythroleukemia cells	GATA1 complex studies
  Primary human HSPCs	Physiologically relevant	Translational research, disease modeling
  CRISPR-edited hematopoietic lines	Precise genetic control	Mutation-specific studies

  The G1E cell system has been particularly valuable for studying GATA1 function, as these GATA1-null erythroblasts can be complemented with wild-type or mutant GATA1 to assess functional consequences .

• What are the technical considerations for using GATA1 (Ab-142) Antibody in chromatin immunoprecipitation (ChIP) assays?

  For successful ChIP experiments with GATA1 (Ab-142) Antibody:

  1. Crosslinking: Use 1% formaldehyde for 10 minutes at room temperature

  2. Chromatin preparation: Sonicate to achieve fragments of 200-500bp

  3. Antibody amount: Use 5-10μg per ChIP reaction

  4. Controls: Include IgG control and positive control genomic regions (known GATA1 binding sites)

  5. Validation: Confirm enrichment at established GATA1 target genes (globin genes, ALAS2)

  ChIP experiments have demonstrated that different GATA1 complexes bind to distinct genomic regions - the GATA1/FOG-1/MeCP1 complex binds to silenced hematopoietic genes, while the GATA1/TAL-1 complex binds to erythroid-specific genes .

• What are the technical limitations when using GATA1 (Ab-142) Antibody in research?

  Be aware of these potential limitations:

  1. The antibody may not distinguish between full-length and short isoforms of GATA1 in some applications

  2. Cross-reactivity with highly homologous GATA family members (GATA2-6) may occur under certain conditions

  3. Phosphorylation at S142 might interfere with antibody binding in some contexts

  4. Non-specific bands may appear in Western blots of certain cell types

  5. The polyclonal nature means batch-to-batch variation can occur

  When encountering unexpected results, consider these limitations and implement additional controls to ensure accurate interpretation of experimental outcomes .

• How can GATA1 (Ab-142) Antibody be used in combination with DNA binding assays?

  To assess GATA1's DNA binding activity:

  1. Perform electrophoretic mobility shift assays (EMSAs) with nuclear extracts immunodepleted using GATA1 (Ab-142) Antibody

  2. Use the antibody for supershift assays to confirm GATA1-DNA complexes

  3. Combine with chromatin immunoprecipitation followed by sequencing (ChIP-seq) to identify genome-wide binding sites

  4. Consider using the native holdup (nHU) assay for quantitative analysis of DNA-GATA1 binding

  Recent studies have employed the nHU assay to characterize how GATA1 mutations affect DNA binding affinities. This assay demonstrated that the short GATA1 isoform, lacking the N-terminal transactivation domain, binds to DNA with increased affinity compared to the full-length protein .

• What experimental controls should be included when using GATA1 (Ab-142) Antibody?

  For rigorous experimental design, include these controls:

  Control Type	Purpose	Implementation
  Positive control	Verify antibody performance	Use K562 cell lysate or recombinant GATA1
  Negative control	Assess non-specific binding	Use non-hematopoietic cell lines
  Loading control	Ensure equal protein loading	Probe for housekeeping proteins (β-actin, GAPDH)
  Isotype control	Background signal assessment	Use non-specific rabbit IgG for IHC/IF/IP
  Biological validation	Functional relevance	Correlate with erythroid differentiation markers

  When studying phosphorylation-dependent events, consider including phosphatase-treated samples to distinguish between total and phosphorylated GATA1 species .